Notably, CHAF1B has been reported to protect against cisplatin-induced cytotoxicity in lung adenocarcinoma and to induce radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma 19, 20. The gene discussed is CHAF1B; the disease is nasopharyngeal carcinoma.